What's another year to such a storied company? Let's have a look at how 2011 treated the chemical giant.
Just the numbers
From a fundamental point of view, DuPont is doing mighty fine. The company has beaten Wall Street's earnings estimates in each of its quarterly reports this year by an average of 14%. GAAP earnings are up by 10% year over year in spite of heavy integration costs from a big acquisition.
The $5.8 billion deal for Danish food-ingredients giant Danisco is transformative even for a company of DuPont's stature and size. The American food-chemicals market has belonged to Monsanto
DuPont also bought silicon-ink maker Innovalight from a consortium of venture backers that included nanotech expert Harris & Harris
So DuPont is keeping an eye on the horizon ahead, not content to rest on its considerable laurels. That's why this is a stock to hold for the next 10 years and beyond. This is exactly the kind of rock-solid stock that will help your retirement portfolio survive the end of Social Security and Medicare.